Watch Watch
Your home of Commercial Ready videos
Watch Watch
Search
Back
Sold Check

Address available on request, Balcatta, WA 6021

+32 Photos
/
Images
Video
Close
×
Sold Check
+34 Photos

Address available on request, Balcatta, WA 6021

Balcatta

SOLD
Address available on request, Balcatta, WA 6021
Properties / Sold / Western Australia / Balcatta
Tenanted Investment
Selling Method
EOI
Selling Details
EOI Campaign
Land Area
8,594 m² (*approx)
Floor Area
3826 m² (*approx)
Property Type
Industrial, Health/Medical
Sub-type
Office/Warehouse, Warehouse Showroom, Health Care & Medical
Terms
10 Years + 5 + 5
Est. Income
$1,511,270 p/a
Fully Leased
Evaris Pharma (Perrigo Australia)
Car Spaces
62
Show All
RARE PHARMACEUTICAL MANUFACTURING FACILITY INVESTMENT OPPORTUNITY
  • Rare Pharmaceutical Manufacturing
  • Triple Net Lease (NNN)
  • Prime Landholding 8,594sqm

RWC Medical is pleased to present an outstanding opportunity to acquire one of Perth's largest and most sought-after pharmaceutical manufacturing facilities. Located in the highly desirable Balcatta industrial precinct, just 10km north of Perth's CBD, this premium asset offers exceptional connectivity, long-term investment security, and unparalleled tenant strength.

Investment Highlights:

• Secure 15-Year Triple Net Lease: Commencing 1 June 2025, with options extending to 2060, providing long-term income certainty.

• Established Pharmaceutical Tenant: Leased to Evaris Pharma (formerly Perrigo Australia), a renowned pharmaceutical company with a 40-year legacy.

• Substantial Income Stream: Generates a net income of $1,511,270 per annum, all outgoings fully covered by the tenant.

• Rare TGA & GMP Certifications: One of Australia's few industrial sites with Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) approvals, making it a highly valuable and hard-to-replicate asset.

• Prime Landholding: Spanning 8,594sqm, the site offers significant long-term capital growth potential in a land-constrained market.

• Strategic Location: Easy access to major arterial routes including the Mitchell Freeway, Reid Highway, and Wanneroo Road, ensuring excellent distribution capabilities.

• Premium Industrial Precinct: Balcatta remains a tightly held market with strong demand from high-quality industrial and commercial occupiers.

• Triple Net Lease (NNN): The tenant is responsible for all outgoings, including property taxes, insurance, maintenance, and capital expenditures, ensuring minimal ownership costs.

Expressions of Interest Close:

Thursday 24th April 2025, 4:00 PM AEST

For further details or to access the data room, please contact the exclusive sales agents:

Franz Stapelberg - Director | +61 430 655 676 | [email protected]

Nicolas Milner - Sales Agent | +61 416 433 217 | [email protected]

Remember to mention you found this property on CommercialReady

Read More
Tenanted Investment
Tenanted Investment

Investment Summary

Property Type
Industrial, Health/Medical
Sub-type
Office/Warehouse, Warehouse Showroom, Health Care & Medical
Est. Income
$1,511,270 p/a
Number Of Tenants
1
Tenant
Evaris Pharma (Perrigo Australia)
Terms
10 Years + 5 + 5
Wale
15 years
Land Area
8,594 m² (*approx)
Floor Area
3826 m² (*approx)
Car Spaces
62
Selling Method
EOI
Selling Details
EOI Campaign

Investment Highlights

RARE PHARMACEUTICAL MANUFACTURING FACILITY INVESTMENT OPPORTUNITY
  • Rare Pharmaceutical Manufacturing
  • Triple Net Lease (NNN)
  • Prime Landholding 8,594sqm

RWC Medical is pleased to present an outstanding opportunity to acquire one of Perth's largest and most sought-after pharmaceutical manufacturing facilities. Located in the highly desirable Balcatta industrial precinct, just 10km north of Perth's CBD, this premium asset offers exceptional connectivity, long-term investment security, and unparalleled tenant strength.

Investment Highlights:

• Secure 15-Year Triple Net Lease: Commencing 1 June 2025, with options extending to 2060, providing long-term income certainty.

• Established Pharmaceutical Tenant: Leased to Evaris Pharma (formerly Perrigo Australia), a renowned pharmaceutical company with a 40-year legacy.

• Substantial Income Stream: Generates a net income of $1,511,270 per annum, all outgoings fully covered by the tenant.

• Rare TGA & GMP Certifications: One of Australia's few industrial sites with Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) approvals, making it a highly valuable and hard-to-replicate asset.

• Prime Landholding: Spanning 8,594sqm, the site offers significant long-term capital growth potential in a land-constrained market.

• Strategic Location: Easy access to major arterial routes including the Mitchell Freeway, Reid Highway, and Wanneroo Road, ensuring excellent distribution capabilities.

• Premium Industrial Precinct: Balcatta remains a tightly held market with strong demand from high-quality industrial and commercial occupiers.

• Triple Net Lease (NNN): The tenant is responsible for all outgoings, including property taxes, insurance, maintenance, and capital expenditures, ensuring minimal ownership costs.

Expressions of Interest Close:

Thursday 24th April 2025, 4:00 PM AEST

For further details or to access the data room, please contact the exclusive sales agents:

Franz Stapelberg - Director | +61 430 655 676 | [email protected]

Nicolas Milner - Sales Agent | +61 416 433 217 | [email protected]

Remember to mention you found this property on CommercialReady

Read More
Tenanted Investment

Property Location

One moment please.

Retrieving map...

Finance Calculator

Address available on request, Balcatta, WA 6021

Secure/no obligation

Step 1

Loan Variables

Adjust the inputs to explore your indicative finance options.

Estimated Purchase Price $x,xxx,xxx
What you intend to pay for the property
Your Contribution: $x,xxx,xxx
The amount you’re investing
LVR: $x,xxx,xxx
Loan to Value Ratio

Estimated Purchase Price:*

What you intend to pay for the property

$

Your Contribution:

The amount you’re investing

Min: 0% - Max: 90% of purchase price.

$

LVR:

Loan to Value Ratio

Min: 10% - Max: 100% of purchase price.

%

Loan Analysis

Estimated Purchase Price:
Your expected purchase price. Final lender valuation may differ and will affect LVR and borrowing.
$x,xxx,xxx
Your Contribution:
Your funds toward the purchase (savings/equity/gift). Does not include costs like duty, legals or LMI.
$xxx,xxx
Loan to Value Ratio:
Calculated as Loan ÷ Price. Guidance only. Lender policy caps vary by property type, location and borrower profile.
xx%
Loan Amount:
Estimated loan based on your inputs. Excludes fees, LMI and costs. Subject to credit assessment and valuation.
in full report
Interest Only: Monthly Repayments
Estimate using interest-only at 5.85% p.a. Excludes fees. Rates can change without notice.
in full report
Principal & Interest: Monthly Repayments
Estimate at 5.85% p.a. over 15 years, monthly compounding. Excludes fees/LMI. Rates may change.
in full report
Stamp Duty: western australia
Indicative rate for western australia. Concessions/exemptions (e.g., first home) may apply and change the amount.
in full report
Stamp Duty Cost:
Estimate only. Check SRO western australia for the latest rules and any concessions that may reduce this figure.
in full report
Address available on request, Balcatta, WA 6021 Balcatta
calculator-icon Yield Calculator
calculator-icon Yield Calculator
calculator-icon
income-icon clear-icon
income-icon clear-icon
income-icon